Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
21st March 2024 • Oncology Today with Dr Neil Love • Research To Practice
00:00:00
01:01:41